30 Day FRN

7396

Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of
respondents

Form name

Pediatric ..................................
Pediatric ..................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................
Adult ........................................

Sociability Form ......................................................................
Saliva Collection Form ...........................................................
CogState Practice Section .....................................................
CogState Baseline Section ....................................................
WAIS IV DS F+B, TOPF ........................................................
Exercise (Bike) Testing ..........................................................
CogState Time 1 Section .......................................................
CogState Time 2 Section .......................................................
CogState Time 3 Section .......................................................
CogState Time 4 Section .......................................................
Visual Analogue Scale for CFS Symptoms ...........................
EQ–5D–Y Health Questionnaire ............................................
PROMIS SF v1—Physical Function .......................................
Physical Fitness and Exercise Activity Levels of Scale .........
International Physical Activity Questionnaire (Self-Administered Long Form).
Physical Activity Readiness Questionnaire ............................
Visual Analogue Scale for CFS Symptoms ...........................
EQ–5D–Y Health Questionnaire ............................................
PROMIS SF v1—Physical Function .......................................
Physical Fitness and Exercise Activity Levels of Scale .........
International Physical Activity Questionnaire (Self-Administered Long Form).
Physical Activity Readiness Questionnaire ............................

Adult
Adult
Adult
Adult
Adult
Adult

........................................
........................................
........................................
........................................
........................................
........................................

Adult ........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–01914 Filed 1–27–21; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–1129]

Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Improving Fetal
Alcohol Spectrum Disorders Prevention
and Practice through National
Partnerships to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on October
13, 2020 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.

VerDate Sep<11>2014

17:16 Jan 27, 2021

Jkt 253001

Number of
participants

The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting

PO 00000

Frm 00044

Fmt 4703

Sfmt 4703

Number of
responses per
participant

Average
burden per
response
(in hrs.)

3
3
109
109
109
64
109
109
109
109
60
60
60
60
60

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1

5/60
5/60
17/60
27/60
10/60
30/60
22/60
12/60
12/60
12/60
8/60
6/60
5/60
2/60
5/60

60
49
49
49
49
49

1
1
1
1
1
1

5/60
8/60
6/60
5/60
2/60
5/60

49

1

5/60

‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Improving Fetal Alcohol Spectrum
Disorders Prevention and Practice
through National Partnerships (OMB
Control No. 0920–1129, Exp. 8/31/
2019)—Reinstatement with Change—
National Centrer for Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National Center on Birth Defects
and Developmental Disabilities
(NCBDDD) seeks to collect training
evaluation data from healthcare
practitioners and staff in health systems
where FASD-related practice and
systems changes are implemented, and
from grantees of national partner
organizations related to prevention,
identification, and treatment of fetal
alcohol spectrum disorders (FASDs).
Prenatal exposure to alcohol is a
leading preventable cause of birth
defects and developmental disabilities.

E:\FR\FM\28JAN1.SGM

28JAN1

7397

Federal Register / Vol. 86, No. 17 / Thursday, January 28, 2021 / Notices
The term ‘‘fetal alcohol spectrum
disorders’’ describes the full continuum
of effects that can occur in an individual
exposed to alcohol in utero. These
effects include physical, mental,
behavioral, and learning disabilities. All
of these have lifelong implications. The
purpose of this program is to build upon
previous efforts from FASD training
programs and shift the perspective from
individual training for practicing
healthcare professionals to one that
capitalizes on prevention opportunities
and the ability to impact health care
practice at the systems level.
Since 2002, CDC funded FASD
Regional Training Centers (RTCs) to
provide education and training to
healthcare professionals and students
about FASD prevention, identification,
and treatment. In July 2013, CDC
convened an expert review panel to
evaluate the effectiveness of the RTC
program overall and to make
recommendations about the program.
The panel highlighted several
accomplishments of the RTCs and
proposed several changes for future

programming: (1) The panel identified a
need for more comprehensive coverage
nationally with discipline-specific
trainings, increased use of technology,
greater collaboration with medical
societies, and stronger linkages with
national partner organizations to
increase the reach of training
opportunities, and (2) The panel
suggested that the training centers focus
on demonstrable practice change and
sustainability and place a stronger
emphasis on primary prevention of
FASDs. In addition, it was
recommended that future initiatives
have stronger evaluation components.
Based on the recommendations of the
expert review panel, CDC is placing
increased focus on prevention,
demonstrating practice change,
achieving national coverage, and
strengthening partnerships between
medical societies and national partner
organizations. While a major focus of
the grantees’ work will be national,
regional approaches will be used to
develop new content and ‘‘test out’’
feasibility and acceptability of materials,

especially among healthcare providers
and medical societies.
CDC requests OMB approval to collect
program evaluation information from (1)
healthcare practitioners from disciplines
targeted by each grantee, including
training participants, and (2) health
system staff.
Healthcare practitioners will complete
surveys to provide information on
whether project trainings impacted their
knowledge and practice behavior
regarding FASD identification,
prevention, and treatment. The
information will be used to improve
future trainings and assess whether
knowledge and practice changes
occurred. Some participants will also
complete qualitative key informant
interviews to gain additional
information on practice change. Health
system employees will be interviewed
or complete surveys as part of activities
to assess readiness of healthcare systems
to implement recommended practice
changes.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Number of
responses per
respondent

Average
burden per
response
(in hours)

Type of
respondents

Form name

Health Professionals ........................
FASD Core Training Participants .....
FASD Core Training Participants .....
Nurses ..............................................
Nurses ..............................................
Certified Medical Assistants and students.
Certified Medical Assistants and students.
Certified Medical Assistants and students.
Pediatricians .....................................
Pediatricians .....................................
Pediatricians .....................................
Pediatricians .....................................
Pediatricians .....................................
Pediatricians .....................................
Family medicine physicians, social
workers, social work students.
Family medicine physicians, social
workers, social work students.
Health Systems Professionals .........

Health Professionals Survey .........................................
FASD Core Training Survey—Pre-Test ........................
FASD Core Training Survey—Post-Test ......................
Health Professionals Survey (Nursing) .........................
Key Informant Interviews with Champions ...................
Medical Assistant—Pre-Test Survey ............................

4,013
4,013
4,013
667
14
334

1
1
1
1
2
1

9/60
9/60
5/60
9/60
45/60
10/60

Medical Assistant—Post-Test Survey ...........................

334

1

10/60

Medical Assistants Change in Practice Survey ............

250

1

15/60

Pre-Test Screening, Assessment, and Diagnosis ........
Post-Test Screening, Assessment, and Diagnosis ......
Pre-Test ND–PAE .........................................................
Post-Test ND–PAE .......................................................
Pre-Test Treatment Across the Lifespan ......................
Post-Test Treatment Across the Lifespan ....................
Social Work and Family Physicians Pre-training Survey.
Social Work and Family Physicians 6-Month Follow
Up Survey.
TCU Organizational Readiness Survey ........................

120
120
120
120
120
120
1,167

1
1
1
1
1
1
1

10/60
10/60
10/60
10/60
7/60
7/60
8/60

1,167

1

8/60

246

2

10/60

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–01916 Filed 1–27–21; 8:45 am]
BILLING CODE 4163–18–P

VerDate Sep<11>2014

17:16 Jan 27, 2021

Jkt 253001

PO 00000

Frm 00045

Fmt 4703

Sfmt 9990

E:\FR\FM\28JAN1.SGM

28JAN1